Throughout the pandemic, men have consistently faced graver outcomes from COVID-19 than women, and science has long searched for the biological thread that explains this disparity. A new study from Washington University, published in JAMA Network Open, offers a surprising turn: among hospitalized men, it was not an abundance of testosterone but its absence that correlated with severity, ventilator use, intensive care, and death. The finding dismantles an early and intuitive hypothesis, replacing certainty with a more humbling question — whether low testosterone is a cause of vulnerability or m
The Indian Express
· May 26, 2021
· health
· 1 min de leitura
Medium
Apuração: Verificado
Study links low testosterone to severe Covid-19 in men
37 patients died during the study, including 25 men, with those having lowest testosterone levels at highest mortality risk.
◉
Health & Medicine
8525 artigos relacionados
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 99% correspondência
Cobertura Relacionada
BBC News · Aug 27
Facebook horse seller ordered to pay damages after selling unfit animals to buyers
Five women report being mis-sold unsafe or injured horses by a Facebook seller, with one buyer's daughter suffering a se…
Al Jazeera · Aug 27 Pakistan hospital fire kills 14 infants; families demand accountabilityFourteen babies died in a fire at Islamabad's Institute of Medical Sciences. Grieving families accuse hospital staff and…
Peter Attia MD · Aug 27 GLP-1 drugs show promise beyond metabolism, but questions remain about whyGLP-1 medications, originally developed for type 2 diabetes, now show potential benefits across metabolic and non-metabo…
Korea JoongAng Daily · Aug 27 Korean researchers identify Erbb4 protein as potential Alzheimer's breakthroughKorean researchers identified the Erbb4 protein as a key driver of Alzheimer's progression, showing it triggers synapse …
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical research on COVID-19 severity has no geopolitical implications; this is a public health study without international relations, strategic, or power dynamics relevance.
Escalation Risk
N/A
Confidence
HIGH
Lente Econômica
📈
Study links low testosterone to severe COVID-19 in men, with potential implications for healthcare costs, pharmaceutical demand, and insurance risk assessment, though causation remains unproven.
Market Signal
neutral
Confidence
LOW
Healthcare and Pharmaceuticals
Medical Diagnostics and Testing
Health Insurance
Biotechnology and Research
Hospital Services
If validated, findings could drive increased testosterone screening and hormone replacement therapy demand among male COVID-19 patients and at-risk populations, potentially increasing out-of-pocket healthcare costs. May also influence insurance premiums and coverage decisions based on hormone levels.
Potential regulatory pathways for testosterone screening protocols in COVID-19 treatment guidelines; possible insurance coverage expansion for hormone testing; increased R&D funding for hormone-based COVID-19 interventions; occupational health policies for high-risk male workers. Requires further validation before policy implementation.